Contact Us


For additional information about clinical trials evaluating yttrium-90 trans-arterial radioembolization (TheraSphere®) therapy in the treatment of liver cancer, please contact:

Clinical Development, BTG
TheraSphereClinical@btgplc.com

For general inquiries, please e-mail us at info@btgplc.com
 Security code